Literature DB >> 11460005

Stability of coagulation proteins in frozen plasma.

B Woodhams1, O Girardot, M J Blanco, G Colesse, Y Gourmelin.   

Abstract

This study reports on the frozen stability of all commonly measured coagulation proteins in normal citrated plasma: activated partial thromboplastin time, prothrombin time (%), thrombin time and fibrinogen (Clauss); clotting assays for factors II, V, VII, VIII, IX, X, XI and XII; functional assays for protein C (clotting), protein S (clotting), antithrombin (chromogenic) and plasminogen (chromogenic); and immunological assays for von Willebrand factor and D-dimer. All these factors listed are stable for up to 3 months if frozen at -24 degrees C or lower. At -74 degrees C, all these factors (allowing for 10% variation) were stable for at least 18 months, most were stable for 24 months. The number of proteins showing > 5% variation over baseline after 6 months storage indicates that some decay does occur even at -74 degrees C. There was no clear advantage in snap freezing at -74 degrees C and then storing at -24 degrees C over both freezing and storing at -24 degrees C; therefore, the freezing process itself is not responsible for the loss of stability. The best stability, especially at -24 degrees C, was obtained when small samples (1 ml) were stored in screw-cap tubes with a minimum dead space. The decrease in stability of the coagulation proteins directly correlates with the effect of temperature and time.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11460005     DOI: 10.1097/00001721-200106000-00002

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  25 in total

1.  Clotting factor deficiency in early trauma-associated coagulopathy.

Authors:  Sandro B Rizoli; Sandro Scarpelini; Jeannie Callum; Bartolomeu Nascimento; Kenneth G Mann; Ruxandra Pinto; Jan Jansen; Homer C Tien
Journal:  J Trauma       Date:  2011-11

2.  Amidolytic, procoagulant, and activation-suppressing proteins produced by contact activation of blood factor XII in buffer solution.

Authors:  Avantika Golas; Chyi-Huey Joshua Yeh; Christopher A Siedlecki; Erwin A Vogler
Journal:  Biomaterials       Date:  2011-09-28       Impact factor: 12.479

3.  Biobanking and international interoperability: samples.

Authors:  Michael Kiehntopf; Michael Krawczak
Journal:  Hum Genet       Date:  2011-07-15       Impact factor: 4.132

4.  Contact activation of blood plasma and factor XII by ion-exchange resins.

Authors:  Chyi-Huey Josh Yeh; Ziad O Dimachkie; Avantika Golas; Alice Cheng; Purnendu Parhi; Erwin A Vogler
Journal:  Biomaterials       Date:  2011-10-06       Impact factor: 12.479

5.  Relation of coagulation factor XI with incident coronary heart disease and stroke: the Cardiovascular Health Study.

Authors:  Duke Appiah; Oluwaseun E Fashanu; Susa R Heckbert; Mary Cushman; Bruce M Psaty; Aaron R Folsom
Journal:  Blood Coagul Fibrinolysis       Date:  2017-07       Impact factor: 1.276

6.  Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH.

Authors:  Y Dargaud; A S Wolberg; E Gray; C Negrier; H C Hemker
Journal:  J Thromb Haemost       Date:  2017-06-28       Impact factor: 5.824

7.  Design and establishment of a biobank in a multicenter prospective cohort study of elderly patients with venous thromboembolism (SWITCO65+).

Authors:  Marie Méan; Drahomir Aujesky; Bernhard Lämmle; Christiane Gerschheimer; Sven Trelle; Anne Angelillo-Scherrer
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

8.  Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism.

Authors:  Jeffrey A Kline; Nury M Steuerwald; John A Watts; Mark Courtney; Herbert L Bonkovsky
Journal:  Thromb Res       Date:  2015-08-28       Impact factor: 3.944

9.  Prospective study of circulating factor XI and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE).

Authors:  Aaron R Folsom; Weihong Tang; Nicholas S Roetker; Susan R Heckbert; Mary Cushman; James S Pankow
Journal:  Am J Hematol       Date:  2015-11       Impact factor: 10.047

10.  Benchtop von Willebrand Factor Testing: Comparison of Commercially Available Ventricular Assist Devices and Evaluation of Variables for a Standardized Test Method.

Authors:  Phillip A Coghill; Suren Kanchi; Zheila J Azartash-Namin; James W Long; Trevor A Snyder
Journal:  ASAIO J       Date:  2019-07       Impact factor: 2.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.